Van Eck Associates Corp Maravai Lifesciences Holdings, Inc. Transaction History
Van Eck Associates Corp
- $78.1 Billion
- Q4 2024
A detailed history of Van Eck Associates Corp transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 2,853 shares of MRVI stock, worth $14,093. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,853
Previous 1,587
79.77%
Holding current value
$14,093
Previous $12,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding MRVI
# of Institutions
227Shares Held
140MCall Options Held
237KPut Options Held
19.4K-
Gtcr LLC20.2MShares$99.5 Million13.05% of portfolio
-
12 West Capital Management LP New York, NY14MShares$69.2 Million12.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$58.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$48.1 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$41.3 Million1.97% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $650M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...